A retrospective study involving review of 71 medical records of patients diagnosed with Hodgkin's Lymphoma between February 2012 and January 2016 was...

Multiple myeloma is the second most common malignant hematologic malignancy which evolved different strategies for immune escape from the host immune...

Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and...

Primary gastrointestinal (GI) T- and NK- cell lymphomas / lymphoproliferative disorders (LPD) are uncommon and they are usually aggressive in nature.

To assess the prognostic value of C-Reactive Protein (CRP), at diagnosis and during follow-up, of patients with Hodgkin’s Lymphoma treated at the...

Linear IgA bullous dermatosis in association with nodal peripheral T cell lymphoma with a T follicular helper phenotype and multiple myeloma: a case...

Preventive versus curative photobiomodulation for oral mucositis in patients with multiple myeloma undergoing hematopoietic stem cell transplantation...

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a distinct subtype of T-cell non-Hodgkin lymphoma that arises in the context of...

Severe and continuous immunoparesis during induction or maintenance therapy in nontransplant patients with multiple myeloma is a sign of poor...

Laboratory reflex testing strategy for the early identification of primary care patients with multiple myeloma.

Research progress of the chemokine/chemokine receptor axes in the oncobiology of multiple myeloma (MM).